Prep1 (pKnox1)-deficiency leads to spontaneous tumor development in mice and accelerates EμMyc lymphomagenesis: A tumor suppressor role for Prep1

Molecular Oncology

Volumn 4, Issue 2, 2010, Pages 126-134

  Longobardi, E ^a,b   Iotti, G ^b   Di Rosa, P ^a   Mejetta, S ^b   Bianchi, F ^b   Fernandez Diaz, L C ^b   Micali, N ^b   Nuciforo, P ^b   Lenti, E ^a   Ponzoni, M ^c   Doglioni, C ^c   Caniatti, M ^d   Di Fiore, P P ^b,e,f   Blasi, F ^a,b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d Istituto di Anatomia Patologica Veterinaria e Patologia Aviare   (Italy)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

EmuMyc; Meis1; Pbx1; Prep1; Tumor suppressor

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE; GENE EXPRESSION; HEPATOCYTE TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MOUSE; NONHUMAN; ONCOGENE MYC; PREP1 GENE; PRIORITY JOURNAL; TISSUE MICROARRAY;

MUS;

EID: 77949263110     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2010.01.001     Document Type: Article

References (31)

1. Adams J.M., Harris A.W., Pinkert C.A., Corcoran L.M., Alexander W.S., Cory S., et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318 (1985) 533-538
2. Azcoitia V., Aracil M., Martínez-A C., and Torres M. The homeodomain protein Meis1 is essential for definitive hematopoiesis and vascular patterning in the mouse embryo. Dev. Biol. 280 (2005) 307-320
3. Berthelsen J., Viggiano L., Schulz H., Ferretti E., Consalez G.G., Rocchi M., et al. PKNOX-1, a gene encoding Prep1, a new regulator of pbx activity, maps on human chromosome 21q22.3 and murine chromosome 17b/c. Genomics 15 (1998) 323-324
4. Berthelsen J., Zappavigna V., Mavilio F., and Blasi F. Prep1, a novel functional partner of Pbx proteins. EMBO J. 17 (1998) 1423-1433
5. Calvo K.R., Knoepfler P.S., Sykes D.B., Pasillas M.P., and Kamps M.P. Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13120-13125
6. De Florian G., Tiso N., Ferretti E., Blasi F., Bortolussi M., and Argenton F. Prep1.1 has essential and unique genetic functions in hindbrain development and neural crest cells differentiation. Development 131 (2004) 613-627
7. Di Rosa P., Villaescusa J.C., Longobardi E., Iotti G., Ferretti E., Diaz V.M., et al. Homeodomain transcription factor Prep1 (pKnox1) is required for hematopoietic stem cells and progenitors activity. Dev. Biol. 311 (2007) 324-334
8. Eischen C.M., Weber J.D., Roussel M.F., Sherr C.J., and Cleveland J.L. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13 (1999) 2658-2669
9. Ferretti E., Marshall H., Pöpperl H., Maconochie M., Krumlauf R., and Blasi F. A complex site including both Pbx-Hox and Prep-Meis-responsive elements and binding a retinoic acid-inducible ternary Hoxb1-Pbx-Prep1 complex is required for HOXB2 rhombomere 4 expression. Development 127 (2000) 155-166
10. Ferretti E., Villaescusa J.C., Di Rosa P., Fernandez-Diaz L.C., Longobardi E., Mazzieri R., et al. Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype. Mol. Cell Biol. 26 (2006) 5650-5662
11. Gorrini C., Squatrito M., Luise C., Syed N., Perna D., Wark L., et al. Tip60 is a haploinsufficient tumor suppressor required for an oncogene-induced DNA damage response. Nature 448 (2007) 1063-1067
12. Harris A.W., Pinkert C.A., Crawford M., Langdon W.Y., Brinster R.L., and Adams J.M. The Eμ-myc transgenic mouse. A model for high incidence spontaneous lymphoma and leukemia in early B cells. J. Exp. Med. 167 (1988) 353-371
13. Hisa T., Spence S.E., Rachel R.A., Fujita M., Nakamura T., Ward J.M., et al. Hematopoietic, angiogenic and eye defects in Meis1 mutant animals. EMBO J. 23 (2004) 450-459
14. Jacobs Y., Schnabel C.A., and Cleary M.L. Trimeric association of Hox and TALE homeodomain proteins mediates Hoxb2 hindbrain enhancer activity. Mol. Cell Biol. 19 (1999) 5134-5142
15. Kamps M.P., Murre C., Sun X.H., and Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60 (1990) 547-555
16. Knoepfler P.S., Calvo K.R., Chen H., Antonarakis S.E., and Kamps M.P. Meis 1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 14553-14558
17. Kononen J., Bubendorf L., Kallioniemi A., Bärlund M., Schraml P., Leighton S., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4 (1998) 844-847
18. Kroon E., Krosl J., Thorsteinsdottir U., Baban S., Buchberg A.M., and Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 17 (1998) 3714-3725
19. Lawrence H.J., Rozenfeld S., Cruz C., Matsukuma K., Kwong A., Kömüves L., et al. Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Leukemia 13 (1999) 1993-1999
20. Moskow J.J., Bullrich F., Huebner K., Daar I.O., and Buchberg A.M. Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice. Mol. Cell Biol. 15 (1995) 5434-5443
21. Nakamura T., Jenkins N.A., and Copeland N.G. Identification of a new family of Pbx-related homeobox genes. Oncogene 13 (1996) 2235-2242
22. Nourse J., Mellentin J.D., Galili N., Wilkinson J., Stanbridge E., Smith S.D., et al. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60 (1990) 535-545
23. Park W.S., Oh R.R., Park J.Y., Yoo N.J., Lee S.H., Shin M.S., et al. Mapping a new target region of allelic loss at 21q22 in primary gastric cancer. Cancer Lett. 159 (2000) 15-21
24. Penkov D., Di Rosa P., Fernandez Diaz L., Basso V., Ferretti E., Grassi F., et al. Involvement of Prep-1 in the αβTCR T-lymphocytic potential of hematopoietic precursors. Mol. Cell Biol. 25 (2005) 10768-10781
25. Selleri L., Depew M.J., Jacobs Y., Chanda S.K., Tsang K.Y., Cheah K.S., et al. Requirement for Pbx1 in skeletal patterning and programming chondrocyte proliferation and differentiation. Development 128 (2001) 3543-3557
26. Thorsteinsdottir U., Kroon E., Jerome L., Blasi F., and Sauvageau G. Defining role for Hox genes and their common collaboration with MEIS1 in the induction of AML. Mol. Cell Biol. 21 (2001) 224-234
27. Wang G.G., Pasillas M.P., and Kamps M.P. Progenitors cells immortalized by HoxA9 + Meis1 show much higher leukemogenicity capacity when transplanted in recipient mice than those immortalized with HoxA9 alone. Blood 106 (2005) 254-264
28. Wong K.F., So C.C., and Kwong Y.L. Chronic myelomonocytic leukemia with t(7;11)(p15;p15) and NUP98/HOXA9 fusion. Cancer Genet. Cytogenet. 115 (1999) 70-72
29. Wong P., Iwasaki M., Somervaille T.C., So C.W., and Cleary M.L. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev. 21 (2007) 2762-2774
30. Wood L.D., Parsons D.W., Jones S., Lin J., Sjöblom T., Leary R.J., et al. The genomic landscape of human breast and colorectal cancers. Science 318 (2007) 1108-1113
31. Zeisig B.B., Milne T., García-Cuéllar M.P., Schreiner S., Martin M.E., Fuchs U., Borkhardt A., Chanda S.K., Walker J., Soden R., Hess J.L., and Slany R.K. Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization. Mol. Cell Biol. 24 (2004) 617-628